scPharmaceuticals Inc. - COM (SCPH)

Historical Portfolio Holders from Q4 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
37.3M
Holdings value Q3 2024
$170M
Value change Q3 2024
+$42.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
93
Number of buys Q3 2024
54
Number of sells Q3 2024
-27
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 37.3M $170M +$42.7M $4.56 93
2024 Q2 27.8M $121M +$4.5M $4.35 77
2024 Q1 26.7M $134M -$7.91M $5.02 76
2023 Q4 28M $175M -$21.5M $6.27 79
2023 Q3 29.9M $213M +$9.11M $7.12 74
2023 Q2 28.5M $291M +$40.7M $10.19 82
2023 Q1 24.6M $223M +$38.8M $9.07 63
2022 Q4 21.4M $154M +$53.5M $7.17 59
2022 Q3 14M $91.3M -$10.8M $6.52 38
2022 Q2 15.7M $75.9M -$3.26M $4.82 37
2022 Q1 15.9M $90.1M -$465K $5.68 34
2021 Q4 15.9M $80M -$1.6M $5.02 29
2021 Q3 16.2M $108M +$1.56M $6.65 29
2021 Q2 16M $97.9M -$7.16M $6.11 35
2021 Q1 17.2M $114M +$1.5M $6.65 45
2020 Q4 16.9M $89.6M -$6.27M $5.29 46
2020 Q3 17.1M $127M -$3.28M $7.45 48
2020 Q2 17.5M $129M +$37.2M $7.36 51
2020 Q1 12.5M $92.4M +$10.2M $7.40 32
2019 Q4 11.1M $62.9M +$1.58M $5.65 27
2019 Q3 7.58M $44.5M +$1.47M $5.89 24
2019 Q2 7.37M $23.5M -$286K $3.19 28
2019 Q1 7.48M $22.5M -$1.28M $3.00 32
2018 Q4 7.85M $29.5M -$830K $3.76 32
2018 Q3 8.06M $47.3M -$193K $5.87 31
2018 Q2 8.09M $45.8M -$6.15M $5.66 37
2018 Q1 8.32M $103M +$6.47M $12.40 37
2017 Q4 7.81M $94.4M +$94.4M $12.09 24